You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PTEN

Showing 1 - 25 of 504
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

PTEN Gene Mutation, PTEN Hamartoma Tumor Syndrome, PTEN Hamartoma Syndrome Trial in Stanford, Boston, Cleveland (Sirolimus,

Not yet recruiting
  • PTEN Gene Mutation
  • +2 more
  • Stanford, California
  • +2 more
Oct 5, 2023

Patients With a Constitutional Alteration of the PTEN Gene

Not yet recruiting
  • PTEN Gene Mutation
    • (no location specified)
    Nov 17, 2022

    Online Neurobehavioral Evaluation Tool for PTEN Patients

    Recruiting
    • PTEN Hamartoma Tumor Syndrome
    • NET
    • University Heights, Ohio
      John Carroll Univeristy
    Jan 3, 2023

    Metastatic Castration-resistant Prostate Cancer Trial in Salt Lake City (Bortezomib)

    Not yet recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • Salt Lake City, Utah
      Huntsman Cancer Institute/University of Utah
    Sep 7, 2023

    PTEN-null Advanced Solid Tumors Trial in New York (Leflunomide)

    Not yet recruiting
    • PTEN-null Advanced Solid Tumors
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Jul 8, 2022

    Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer Trial (MEN1611, Eribulin)

    Not yet recruiting
    • Breast Cancer
    • +2 more
    • (no location specified)
    Apr 12, 2023

    Advanced Cancers, Solid Tumors Trial in Houston (Pazopanib, Everolimus)

    Active, not recruiting
    • Advanced Cancers
    • Solid Tumors
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Dec 16, 2022

    PTEN Expression in Functional and Pathological Endometrial

    Completed
    • Endometrial Hyperplasia
    • Endometrial Adenocarcinoma
    • routine stain by H&E.
    • Sohag, Egypt
      Maisa Hashem Mohammed
    Jul 13, 2022

    High-Risk Prostate Cancer Trial in Portland (Capivasertib, abiraterone acetate)

    Not yet recruiting
    • High-Risk Prostate Cancer
    • Portland, Oregon
      VA Portland Health Care System, Portland, OR
    Jan 17, 2023

    PTEN Gene Mutation, PTEN Hamartoma Tumor Syndrome Trial in Palo Alto, Boston, Cleveland (RAD001, Placebo)

    Completed
    • PTEN Gene Mutation
    • PTEN Hamartoma Tumor Syndrome
    • Palo Alto, California
    • +2 more
    Feb 7, 2022

    Partial PTEN Deletion in Breast Cancer

    Not yet recruiting
    • PTEN Gene Deletion
      • (no location specified)
      Oct 27, 2021

      Advanced Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 Trial in Houston

      Recruiting
      • Advanced Breast Carcinoma
      • +17 more
      • Houston, Texas
        M D Anderson Cancer Center
      Dec 5, 2022

      Endometrial Cancer, Ovarian Cancer Trial in Houston (Copanlisib, fulvestrant)

      Recruiting
      • Endometrial Cancer
      • Ovarian Cancer
      • Houston, Texas
        M D Anderson Cancer Center
      Sep 27, 2022

      Melanoma and Other Malignant Tumors of Skin, Metastatic Melanoma Trial in Houston (GSK2636771, Pembrolizumab)

      Active, not recruiting
      • Melanoma and Other Malignant Neoplasms of Skin
      • Metastatic Melanoma
      • Houston, Texas
        University of Texas MD Anderson Cancer Center
      Sep 22, 2022

      PTEN Gene Mutation, PTEN Hamartoma Tumor Syndrome, PTEN Hamartoma Syndrome Trial in Columbus (Sirolimus)

      Recruiting
      • PTEN Gene Mutation
      • +6 more
      • Columbus, Ohio
        The Ohio State University Wexner Medical Center
      Nov 12, 2021

      Cancer, Solid Tumors Trial in United States (Vevorisertib, Fulvestrant, Paclitaxel)

      Terminated
      Has Results
      • Cancer
      • Solid Tumors
      • Las Vegas, Nevada
      • +5 more
      Jun 14, 2022

      Recurrent Glioblastoma Trial in Zhengzhou (Tislelizumab plus Bevacizumab)

      Recruiting
      • Recurrent Glioblastoma
      • Tislelizumab plus Bevacizumab
      • Zhengzhou, Henan, China
        Henan Provincial People's Hospital
      Sep 11, 2022

      Individuals With Autism and Germline Heterozygous PTEN Mutations

      Recruiting
      • PTEN
      • +4 more
        • Los Angeles, California
        • +4 more
        Jul 29, 2021

        Breast Cancer, Tumor Metastasis Trial in Houston (Trastuzumab, RAD001)

        Completed
        Has Results
        • Breast Cancer
        • Neoplasm Metastasis
        • Houston, Texas
          UT MD Anderson Cancer Center
        Sep 30, 2022

        Advanced Solid Tumor, PIK3CA Mutation, PTEN Loss of Function Mutation Trial in United States (Serabelisib, Insulin Suppressing

        Recruiting
        • Advanced Solid Tumor
        • +2 more
        • Birmingham, Alabama
        • +9 more
        May 25, 2022

        Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Taselisib)

        Active, not recruiting
        • Advanced Lymphoma
        • +5 more
        • Philadelphia, Pennsylvania
          ECOG-ACRIN Cancer Research Group
        Feb 4, 2022

        Recurrent Glioma, Recurrent Glioblastoma, Poly ADP Ribose Polymerase (PARP) Inhibitor Trial in Hong Kong (Talazoparib)

        Recruiting
        • Recurrent Glioma
        • +4 more
        • Hong Kong, Hong Kong
          Department of Clinical Oncology
        Aug 19, 2021

        High Risk Prostate Cancer to Determine Prognosis

        Active, not recruiting
        • Prostate Cancer
          • Gatineau, Quebec, Canada
          • +7 more
          Sep 20, 2021

          ARID1A Gene Mutation, ATM Gene Mutation, ATR Gene Mutation Trial in United States (Olaparib)

          Recruiting
          • ARID1A Gene Mutation
          • +15 more
          • Scottsdale, Arizona
          • +4 more
          Dec 13, 2022

          Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid System Tumor Trial in Philadelphia (Biopsy,

          Active, not recruiting
          • Advanced Lymphoma
          • +5 more
          • Biopsy
          • +3 more
          • Philadelphia, Pennsylvania
            ECOG-ACRIN Cancer Research Group
          Aug 5, 2022